| Released | Contributor | Author | Title | Pages | Price |
| 1-Dec-2009 | New Constructs, LLC |
N/A
| DVA: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 |
| 1-Dec-2009 | Pechala's Reports | Lubomir Pechala | DAVITA INC (DVA=US) - REPORT FOR ACTIVE TRADERS | 4 |
$25 |
| 30-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for HOSPITALS | 18 |
$49 |
| 30-Nov-2009 | Reuters Investment Profile |
N/A
| DaVita Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 30-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Health Care Industry Market Research and Competitive Analysis 2010 | 730 |
$299 |
| 30-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Plunkett's Health Care Technologies Overview 2010 (Summary) | 80 |
$199 |
| 30-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Health Care Industry Trends, Statistics & Analysis 2010 (Summary) | 98 |
$199 |
| 30-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for DVA | 13 |
$25 |
| 30-Nov-2009 | Market Edge |
N/A
| Market Edge Equity Research Report | 4 |
$10 |
| 29-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Davita has a current Overall Rating of B (Positive). | 7 |
$25 |
0.34% Nasdaq 0.00%
Research Reports
